SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manifold Albert Jude
(Last) (First) (Middle)
C/O CRH PLC
STONEMASON'S WAY
(Street)
RATHFARNHAM DUBLIN L2 D16 KH51
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CRH PUBLIC LTD CO [ CRH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/28/2025 S 7,000(1) D $100.8158(2)(3) 80,083 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person's sale of Ordinary Shares reported in this Form 4 was matchable to non-exempt automatic dividend reinvestments that occurred in December 2024 and October 2024, respectively, and were reported on Forms 8-K on December 26, 2024 (acquiring 4.640876 Ordinary Shares at a price of $93.04 per share) and October 4, 2024 (acquiring 4.674931 Ordinary Shares at a price of $91.915920 per share), respectively (the "Dividend Reinvestments"). The Reporting Person retired from his position as Chief Executive Officer and as a member of the Board of Directors of the Issuer, effective December 31, 2024, and therefore a Form 3 was not filed in connection with the Issuer's transition to U.S. domestic issuer reporting status, effective January 1, 2025.
2. The Reporting Person has preemptively disgorged $84.63 to the Issuer, representing the full amount of the profit realized on the differential between the above-mentioned sale and the Dividend Reinvestments.
3. The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $100.13 and $101.56, inclusive, of shares sold on the New York Stock Exchange. Full information regarding the number of shares sold at each separate price in the range will be provided to the SEC upon request.
Remarks:
Former Executive Officer & Director
/s/ Neil Colgan, attorney-in-fact for Albert Jude Manifold 03/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
CRH (NYSE:CRH)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more CRH Charts.
CRH (NYSE:CRH)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more CRH Charts.